21 Aug 2024 --- Food technology company De Novo Foodlabs receives new capital, bringing its total investment to US$4 million. With the new funds, the company can fast-track the commercialization of its precision fermented lactoferrin product, NanoFerrin, as an animal-free alternative to current lactoferrin sources without ethical and environmental drawbacks. Lactoferrin is a globular glycoprotein found in milk and other mammalian secretions that plays a crucial role in infant development. Additionally, De Novo Foodlabs highlights its health benefits for adults, including improved immunity, brain health, iron absorption, gut health and longevity. Research shows the protein effectively alleviates aging-related changes with its antioxidant, anti-cellular senescence and anti-inflammation properties.
